The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pembrolizumab, GX-188E, and GX-I7 in patients with human papillomavirus-16- and/or 18-positive head and neck squamous cell carcinoma: Single-arm, phase 2 trial with single cell transcriptomic analysis and artificial intelligence-powered spatial analysis.
 
Hye Ryun Kim
Speakers' Bureau - Ono Pharmaceutical; Roche/Genentech
 
Chang Gon Kim
Consulting or Advisory Role - Amgen; Novartis; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Takeda
Research Funding - Daewoong Pharmaceutical; Yuhan
 
June-Young Koh
Employment - Genome Insight
Stock and Other Ownership Interests - Genome Insight
 
Min Hee Hong
Stock and Other Ownership Interests - GI biome; GI cell
Honoraria - AstraZeneca; AstraZeneca; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Yuhan
Research Funding - Yuhan
 
Hyun Jun Hong
No Relationships to Disclose
 
DaHee Kim
No Relationships to Disclose
 
Nam Suk Sim
No Relationships to Disclose
 
Sun Och Yoon
No Relationships to Disclose
 
Gamin Kim
No Relationships to Disclose
 
Jung Eun Lee
No Relationships to Disclose
 
Wonrak Son
No Relationships to Disclose
 
Chang Lee
No Relationships to Disclose
 
Kyung Hwan Kim
No Relationships to Disclose
 
Jeong Seok Lee
No Relationships to Disclose
 
Donggeun Yoo
No Relationships to Disclose
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Medpacto; Y-Biologics
Consulting or Advisory Role - Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics
 
Yoon Woo Koh
No Relationships to Disclose